[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368704-105":59,"doc-detail-368704-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeting-grpr-for-sex-hormone-dependent-cancer-after-loss-of-e-cadherin","Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin","","Sex inequalities in cancer are well documented, yet limited understanding restricts progress in precision medicine. The study emphasizes that ethnicity, age and sex shape both incidence and treatment response, with age-related hormone production often underestimated in cancers not recognized as hormone dependent. Using premenopausal female vulnerability, the work identifies E-cadherin as essential in oestrogen signalling and reveals a GRPR–oestrogen-sensitizing pathway. Blocking this pathway reduces metastasis in mice, supporting therapeutic targeting of GRPR or oestrogen receptor-α.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-grpr-for-sex-hormone-dependent-cancer-after-loss-of-e-cadherin/368704/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-grpr-for-sex-hormone-dependent-cancer-after-loss-of-e-cadherin/368704.png","ImageObject",300,407,{"name":92,"@type":93},"Terk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is sex-specific biology considered important in cancer management?","Question",{"text":112,"@type":113},"Because sex, age and related hormone production can drive differences in cancer incidence and response to treatment, which affects prevention and therapy strategies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role does E-cadherin play in oestrogen-related cancer biology?",{"text":117,"@type":113},"E-cadherin is identified as a crucial component of oestrogen response, linking hormone signalling to tumour behaviour across cancers including melanoma.",{"name":119,"@type":110,"acceptedAnswer":120},"How does targeting GRPR or oestrogen receptor-α affect disease progression?",{"text":121,"@type":113},"In a mouse melanoma model, inhibiting the GRPR–oestrogen pathway by targeting GRPR or oestrogen receptor-α reduces metastasis, indicating therapeutic potential.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368704,1791192523,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \n\n| Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin |  |  |\n| --- | --- | --- |\n| [https://doi.org/10.1038/s41586-025-09111-x](https://doi.org/10.1038/s41586-025-09111-x)\u003Cbr>Received: 9 October 2023 Accepted: 7 May 2025 Published online: 11 June 2025 Open access\u003Cbr> Check for updates | Jérémy H. Raymond1,2, Zackie Aktary1,2, Marie Pouteaux1,2, Valérie Petit1,2, Flavie Luciani1,2, Maria Wehbe1,2, Patrick Gizzi3, Claire Bourban3, Didier Decaudin4, Fariba Nemati4,\u003Cbr>Igor Martianov5, Irwin Davidson5, Catherine-Laure Tomasetto5, Richard M. White6, Florence Mahuteau-Betzer7,8, Béatrice Vergier9, Lionel Larue1,2,10✉ & Véronique Delmas1,2,10\u003Cbr>Sex inequalities in cancer are well documented, but the current limited understanding is hindering advancesin precision medicine and therapies1. Consideration of ethnicity, age and sex is essential for the management of cancer patients because they underlie important differences in both incidence and response to treatment2,3. Age-related hormone production, which is a consistent divergence between the sexes, is underestimatedin cancers that are not recognized as being hormone dependent4–6. Here, we show that premenopausal women have increased vulnerability to cancers, and we identify the cell–cell adhesion molecule E-cadherinasa crucial component in theoestrogen response in various cancers, including melanoma. Ina mouse model of melanoma, we discovered anoestrogen-sensitizing pathway connecting E-cadherin,β-catenin, oestrogen receptor-α and GRPR that promotes melanoma aggressiveness in women. Inhibiting this pathway by targeting GRPRoroestrogen receptor-α reduces metastasis in mice, indicating its therapeutic potential. Our study introducesa concept linking hormone sensitivity and tumour phenotype in which hormones affect cell phenotype and aggressiveness. We have identified an integrated pro-tumour pathway in women and propose that targeting aG-protein-coupled receptor with drugs not commonly used for cancer treatment could be more effective in treating E-cadherindependent cancersin women. This study emphasizes the importance of sex-specific factors in cancer management and offers hope of improving outcomesin various cancers. |  |\n| Cancer, which is one of the leading causes of premature mortality in |  | and Extended Data Fig. 1a). Of 24 cancer types analysed, 13 showed a |\n| humans, is known to have multiple risk factors. Some of these factors are intrinsic to the tumour or cell of origin, but many are extrinsic, |  | significant female bias during this period (P = 0.0248; Extended Data Fig. 1a–fand Supplementary Table 1), with malignant melanoma being |\n| originating from the tumour environment or individual behaviour. Sex |  | the most prominent (Fig. 1band Extended Data Fig. 1c). Melanoma |\n| and age have various effects on tissue and tumour exposure in cancer |  | occurs most frequently in pregnant women and those exposed to high |\n| biology, but their role and, most importantly, their interactions remain |  | oestrogen levels during puberty8–10. This coincides with peak oestradiol |\n| poorly understood. Epidemiological data have revealed numerous sex |  | levels in young women, whereas testosterone remains stable across |\n| differences in the incidence of various cancers in non-reproductive |  | ages, underscoring the potential role of oestrogen in initiating cancer |\n| organs, although the role of sex hormones is sometimes suspected but |  | (Fig. 1cand Extended Data Fig. 1g). |\n| little studied1,6,7. Understanding these sex-and age-related dynamics is essential for improving prevention and treatment strategies. |  | Genes central to the main female-biased cancers (melanoma, gastricand thyroid), breast cancer andESR1, which encodes oestrogen receptor-α (ERα), include CDH1 (which encodes E-cadherin), CCND1 |\n| E-cadherinasanoestrogen regulator |  | (cyclin D1), BRAFand KRAS (Fig. 1d and Supplementary Table 2) . Of these, only CDH1 mRNA levels were lowe","cbCaifkIep5PZ5gl","https://ap.wps.com/l/cbCaifkIep5PZ5gl","pdf",41500990,35,"English","# Introduction\n## Sex and age differences in cancer susceptibility\n## Hormone regulation and E-cadherin\n# Results and Mechanistic Model\n## E-cadherin hub in oestrogen-mediated cancer\n## GRPR–oestrogen-sensitizing pathway\n## Therapeutic targeting and metastasis reduction\n# Conclusion and Implications","[{\"question\":\"Why is sex-specific biology considered important in cancer management?\",\"answer\":\"Because sex, age and related hormone production can drive differences in cancer incidence and response to treatment, which affects prevention and therapy strategies.\"},{\"question\":\"What role does E-cadherin play in oestrogen-related cancer biology?\",\"answer\":\"E-cadherin is identified as a crucial component of oestrogen response, linking hormone signalling to tumour behaviour across cancers including melanoma.\"},{\"question\":\"How does targeting GRPR or oestrogen receptor-α affect disease progression?\",\"answer\":\"In a mouse melanoma model, inhibiting the GRPR–oestrogen pathway by targeting GRPR or oestrogen receptor-α reduces metastasis, indicating therapeutic potential.\"}]","Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin | PDF",1790178129,88,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0dee066884326b2107c02b33a175c67e.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6825d0310ad14a0280f25c42f304c6bf.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf8e8130c226a3b2eb2c43b32be3276e.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/353b37f37adfeaa30d0d1bb2d4966889.webp",980,1301]